After amending the deal, Bioventus completes purchase of Israeli company CartiHeal
Bioventus has completed the acquisition of CartiHeal, an Israeli firm, following a decision to amend the deal earlier this year.
Read More
cartiheal
A week after announcing, Durham’s Bioventus says it will cancel $415M debt funding round
Bioventus has withdrawn a $415 million offering of senior notes, one week after announcing that the company would raise funds to close a recent acquisition.
Read More
Bioventus completes acquisition of Israeli firm CartiHeal in deal worth up to $450M
Bioventus has chosen to exercise its option to acquire an Israeli firm, CartiHeal, following the premarket approval of its technology by the U.S. FDA.
Read More
Bioventus invests $2.5M in Israeli joint implant company CartiHeal
Bioventus, a global orthobiologics company headquartered in Durham, has invested $2.5 million in an Israeli company that has developed an implant for treating osteoarthritic knees.
Read More
